Skip to content
1st Counsel – Lifestyle
Author:
Model N
Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026
Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12
May 5, 2026
Model N Appoints Thomas Gibbs to Board of Directors
May 5, 2026
Model N Manages $1.3 Trillion in Gross Revenue for Life Sciences Customers
April 21, 2026